Cor.Sync

Cor.Sync

Empowering rapid and accurate decisions for ischemic cardiovascular emergencies with an advanced diagnostic tool and insightful clinical support platform.

Founded 2019 11-50 employees Pre-Seed Total: $5.02M Biotechnology, Health Care +1

Cor.Sync is a biotechnology startup founded in 2019, focusing on revolutionizing emergency care for ischemic cardiovascular diseases. The company's slogan "Empowering rapid and accurate decisions for ischemic cardiovascular emergencies with an advanced diagnostic tool and insightful clinical support platform" reflects its commitment to leveraging technology for enhanced medical diagnostics and decision-making. Cor.Sync's innovative solution includes a point-of-care device capable of measuring troponin levels with laboratory precision in just 8 minutes - a remarkable feat in emergency medical settings. Paired with this device is a clinical decision aid platform that utilizes a machine learning algorithm to analyze the test results, providing healthcare professionals with a dashboard of insights to support evidence-based medicine. In March 2022, Cor.Sync secured a significant Pre Seed Round investment of BRL850.00K from DOMO.VC and Unimed VTRP, indicating investor confidence in the potential of the company's innovation within the Health Care and Life Sciences industries. This recent funding round not only signifies external validation of Cor.Sync's business model and technology but also provides the financial resources necessary for the company to pursue its growth and development strategies. As the startup continues to make strides in the healthcare sector, its combination of cutting-edge diagnostics and clinical support platforms could prove to be a game-changer in improving patient outcomes in emergency cardiovascular care.

Funding Stage	Amount	Investors	Lead Investors	Date
Pre Seed Round	BRL850.00K	2	DOMO.VC, Unimed VTRP	01 Mar 2022
Pre Seed Round	BRL700.00K	2	DOMO.VC, Bold Capital	10 May 2021
Angel Round	BRL150.00K	1	HARDS	30 Jul 2020
Grant	BRL3.32M	4	FINEP, NTT Data +2	01 Jan 2020

Funding Stage

Amount

Investors

Lead Investors

Date

Pre Seed Round

BRL850.00K

DOMO.VC, Unimed VTRP

01 Mar 2022

Pre Seed Round

BRL700.00K

DOMO.VC, Bold Capital

10 May 2021

Angel Round

BRL150.00K

HARDS

30 Jul 2020

Grant

BRL3.32M

FINEP, NTT Data +2

01 Jan 2020

FAQ About Cor.Sync

Empowering rapid and accurate decisions for ischemic cardiovascular emergencies with an advanced diagnostic tool and insightful clinical support platform.

Cor.Sync was founded in 2019.

Cor.Sync operates in Biotechnology, Health Care and Life Sciences. Its work centres on cardiovascular diagnostics, emergency care, point-of-care device and troponin level measurement.

Cor.Sync has approximately 11-50 employees.

Cor.Sync has completed 4 funding rounds, raising a total of $5.02M. The latest funding stage is Pre-Seed.

Top alternatives and competitors to Cor.Sync include Droplite, Bilimetrix s.r.l., Dascena, Response Biomedical Corp., Linear Diagnostics Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Cor.Sync and Droplite are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Cor.Sync

Funding Rounds & Investors (4)

Cor.Sync Alternatives & Competitors

FAQ About Cor.Sync